Benjamin J. Daverman

Ben joined GTCR in 2008. Prior to joining GTCR, he worked as a Venture Capitalist at Alta Partners, as well as an Investment Banking Associate at JMP Securities and an Analyst in the Mergers & Acquisitions group at J.P. Morgan (formerly Hambrecht & Quist). He holds an MBA from the Wharton School at the University of Pennsylvania and a BA in history magna cum laude from Colgate University. Ben also holds a master’s degree in biotechnology from the School of Applied Sciences & Engineering at the University of Pennsylvania.

Ben is currently a Director of TerSera Therapeutics, Maravai LifeSciences, and XIFIN. He was previously on the boards of Actient Pharmaceuticals, Cole-Parmer, Cord Blood Registry, Crealta Pharmaceuticals, Devicor Medical Products, GeneraMedix, and Sterigenics.